The assessment of the spondyloarthritis international society concept and criteria for the classification of axial spondyloarthritis and peripheral spondyloarthritis: A critical appraisal for the pediatric rheumatologist

Pediatric Rheumatology

Volumn 10, Issue , 2012, Pages

  Burgos Vargas, Ruben ^a  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

Ankylosing spondylitis; ASAS criteria; Enthesitis related arthritis; Juvenile as; Juvenile spa; Spondyloarthritis

Indexed keywords

ETANERCEPT; INFLIXIMAB; TUMOR NECROSIS FACTOR INHIBITOR;

ANKYLOSING SPONDYLITIS; ARTHRITIS; BACKACHE; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; ENTHESITIS; HUMAN; INFLAMMATORY BACK PAIN; JUVENILE RHEUMATOID ARTHRITIS; JUVENILE SPONDYLOARTHRITIS; LABORATORY TEST; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PATHOPHYSIOLOGY; PEDIATRICS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; REVIEW; RHEUMATOLOGY; RISK FACTOR; SACROILIITIS; SPINE RADIOGRAPHY; SPONDYLARTHRITIS; SYMPTOM; TREATMENT RESPONSE; UVEITIS;

EID: 84861611967     PISSN: None     EISSN: 15460096     Source Type: Journal    
DOI: 10.1186/1546-0096-10-14     Document Type: Review

References (74)

1. Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007, 369(9570):1379-1390. 10.1016/S0140-6736(07)60635-7, 17448825.
2. Weisman MH, Reveille JD, van der Heijde D. Ankylosing Spondylitis and the Spondyloarthropathies: A Companion to Rheumatology 2006, Mosby, Philadelphia, 1.
3. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984, 27(4):361-368. 10.1002/art.1780270401, 6231933.
4. Kobelt G, Andlin-Sobocki P, Maksymowych WP. Costs and quality of life of patients with ankylosing spondylitis in Canada. J Rheumatol 2006, 33(2):289-295.
5. Ariza-Ariza R, Hernandez-Cruz B, Navarro-Sarabia F. Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis. Arthritis Rheum 2003, 49(4):483-487. 10.1002/art.11197, 12910553.
6. Chorus AM, Miedema HS, Boonen A, Van Der Linden S. Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Ann Rheum Dis 2003, 62(12):1178-1184. 10.1136/ard.2002.004861, 1754383, 14644855.
7. Bakland G, Gran JT, Nossent JC. Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis 2011, 70(11):1921-1925. 10.1136/ard.2011.151191, 21784726.
8. Zochling J, Braun J. Mortality in rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 2009, 27. (4 Suppl 55).
9. Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J. How to diagnose axial spondyloarthritis early. Ann Rheum Dis 2004, 63(5):535-543. 10.1136/ard.2003.011247, 1754994, 15082484.
10. Rudwaleit M, Landewe R, van der Heijde D, Listing J, Brandt J, Braun J. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 2009, 68(6):770-776. 10.1136/ard.2009.108217, 19297345.
11. Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009, 68(6):777-783. 10.1136/ard.2009.108233, 19297344.
12. Rudwaleit M, van der Heijde D, Landewe R, Akkoc N, Brandt J, Chou CT. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011, 70(1):25-31. 10.1136/ard.2010.133645, 21109520.
13. Riley MJ, Ansell BM, Bywaters EG. Radiological manifestations of ankylosing spondylitis according to age at onset. Ann Rheum Dis 1971, 30(2):138-148. 10.1136/ard.30.2.138, 1005741, 5569434.
14. Marks SH, Barnett M, Calin A. A case-control study of juvenile- and adult-onset ankylosing spondylitis. J Rheumatol 1982, 9(5):739-741.
15. Calin A, Elswood J. The natural history of juvenile-onset ankylosing spondylitis: a 24-year retrospective case-control study. Br J Rheumatol 1988, 27(2):91-93. 10.1093/rheumatology/27.2.91, 3365541.
16. Garcia-Morteo O, Maldonado-Cocco JA, Suarez-Almazor ME, Garay E. Ankylosing spondylitis of juvenile onset: comparison with adult onset disease. Scand J Rheumatol 1983, 12(3):246-248. 10.3109/03009748309098542, 6623013.
17. Burgos-Vargas R, Naranjo A, Castillo J, Katona G. Ankylosing spondylitis in the Mexican mestizo: patterns of disease according to age at onset. J Rheumatol 1989, 16(2):186-191.
18. Baek HJ, Shin KC, Lee YJ, Kang SW, Lee EB, Yoo CD. Juvenile onset ankylosing spondylitis (JAS) has less severe spinal disease course than adult onset ankylosing spondylitis (AAS): clinical comparison between JAS and AAS in Korea. J Rheumatol 2002, 29(8):1780-1785.
19. Stone M, Warren RW, Bruckel J, Cooper D, Cortinovis D, Inman RD. Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis. Arthritis Rheum 2005, 53(3):445-451. 10.1002/art.21174, 15934110.
20. Gensler LS, Ward MM, Reveille JD, Learch TJ, Weisman MH, Davis JC. Clinical, radiographic and functional differences between juvenile-onset and adult-onset ankylosing spondylitis: results from the PSOAS cohort. Ann Rheum Dis 2008, 67(2):233-237. 10.1136/ard.2007.072512, 17604288.
21. O'Shea FD, Boyle E, Riarh R, Tse SM, Laxer RM, Inman RD. Comparison of clinical and radiographic severity of juvenile-onset versus adult-onset ankylosing spondylitis. Ann Rheum Dis 2009, 68(9):1407-1412. 10.1136/ard.2008.092304, 18782793.
22. Ozgocmen S, Ardicoglu O, Kamanli A, Kaya A, Durmus B, Yildirim K. Pattern of disease onset, diagnostic delay, and clinical features in juvenile onset and adult onset ankylosing spondylitis. J Rheumatol 2009, 36(12):2830-2833. 10.3899/jrheum.090435, 19884272.
23. Ploski R, Flato B, Vinje O, Maksymowych W, Forre O, Thorsby E. Association to HLA-DRB1*08, HLA-DPB1*0301 and homozygosity for an HLA-linked proteasome gene in juvenile ankylosing spondylitis. Hum Immunol 1995, 44(2):88-96. 10.1016/0198-8859(95)00063-A, 8847233.
24. Maksymowych WP, Jhangri GS, Gorodezky C, Luong M, Wong C, Burgos-Vargas R. The LMP2 polymorphism is associated with susceptibility to acute anterior uveitis in HLA-B27 positive juvenile and adult Mexican subjects with ankylosing spondylitis. Ann Rheum Dis 1997, 56(8):488-492. 10.1136/ard.56.8.488, 1752428, 9306872.
25. Maksymowych WP, Gorodezky C, Olivo A, Alaez C, Wong C, Burgos-Vargas R. HLA-DRB1*08 influences the development of disease in Mexican Mestizo with spondyloarthropathy. J Rheumatol 1997, 24(5):904-907.
26. Kruithof E, Van den Bossche V, De Rycke L, Vandooren B, Joos R, Canete JD. Distinct synovial immunopathologic characteristics of juvenile-onset spondylarthritis and other forms of juvenile idiopathic arthritis. Arthritis Rheum 2006, 54(8):2594-2604. 10.1002/art.22024, 16868982.
27. Wright and Moll Seronegative Polyarthritis. Amsterdam 1976, Elsevier/North Holland Publishing, , Wright and Moll.
28. Burgos-Vargas R, Pacheco-Tena C, Vazquez-Mellado J. Juvenile-onset spondyloarthropathies. Rheum Dis Clin North Am 1997, 23(3):569-598. 10.1016/S0889-857X(05)70348-3, 9287378.
29. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004, 31(2):390-392.
30. Boyer GS, Templin DW, Bowler A, Lawrence RC, Heyse SP, Everett DF. Spondyloarthropathy in the community: clinical syndromes and disease manifestations in Alaskan Eskimo populations. J Rheumatol 1999, 26(7):1537-1544.
31. Roux CH, Saraux A, Le Bihan E, Fardellone P, Guggenbuhl P, Fautrel B. Rheumatoid arthritis and spondyloarthropathies: geographical variations in prevalence in France. J Rheumatol 2007, 34(1):117-122.
32. Collantes E, Zarco P, Munoz E, Juanola X, Mulero J, Fernandez-Sueiro JL. Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) extended report. Rheumatology (Oxford) 2007, 46(8):1309-1315.
33. Chou CT, Lin KC, Wei JC, Tsai WC, Ho HH, Hwang CM. Study of undifferentiated spondyloarthropathy among first-degree relatives of ankylosing spondylitis probands. Rheumatology (Oxford) 2005, 44(5):662-665.
34. Khan MA, van der Linden SM, Kushner I, Valkenburg HA, Cats A. Spondylitic disease without radiologic evidence of sacroiliitis in relatives of HLA-B27 positive ankylosing spondylitis patients. Arthritis Rheum 1985, 28(1):40-43. 10.1002/art.1780280107, 3871329.
35. Prakash S, Bansal R, Rajagopalan P, Malaviya AN. Immunological studies in seronegative spondyloarthropathies. Br J Rheumatol 1983, 22(3):146-150. 10.1093/rheumatology/22.3.146, 6606468.
36. Burns TM. Undifferentiated spondyloarthropathy. Spondyloarthropathies 1984, 253-264. Grune & Stratton, Orlando, FL, Calin A.
37. Amor B, Dougados M, Mijiyawa M. Criteria of the classification of spondylarthropathies. Rev Rheum Mal Osteoartic 1990, 57(2):85-89.
38. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991, 34(10):1218-1227. 10.1002/art.1780341003, 1930310.
39. Burgos-Vargas R. Undifferentiated spondyloarthritis: a global perspective. Curr Rheumatol Rep 2007, 9(5):361-366. 10.1007/s11926-007-0058-2, 17915091.
40. Burgos-Vargas R, Casasola-Vargas JC. From retrospective analysis of patients with undifferentiated spondyloarthritis (SpA) to analysis of prospective cohorts and detection of axial and peripheral SpA. J Rheumatol 2010, 37(6):1091-1095. 10.3899/jrheum.100413, 20516036.
41. Mau W, Zeidler H, Mau R. Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup. J Rheumatol 1988, 15:1109-1114.
42. Kumar A, Bansal M, Srivastava DN. Long-term outcome of undifferentiated spondylarthropathy. Rheumatol Int 2001, 20:221-224. 10.1007/s002960100116, 11563579.
43. Sampaio-Barros PD, Bertolo MB, Kraemer MH. Undifferentiated spondyloarthropathies: a 2-year follow-up study. Clin Rheumatol 2001, 20:201-206. 10.1007/s100670170066, 11434474.
44. Sany J, Rosenberg F, Panis G, Serre H. Unclassified HLA-B27 inflammatory rheumatic diseases: followup of 23 patients. Arthritis Rheum 1980, 23:258-259. 10.1002/art.1780230223, 6965860.
45. Schattenkirchner M, Krüger K. Natural course and prognosis of HLA-B27-positive oligoarthritis. Clin Rheumatol 1987, 6(Suppl 2):83-86.
46. Huerta-Sil G, Casasola-Vargas JC, Londoño JD. Low grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling diagnostic criteria for ankylosing spondylitis throughout follow up. Ann Rheum Dis 2006, 65:642-646. 10.1136/ard.2005.043471, 1798115, 16219705.
47. Sampaio-Barros PD, Bortoluzzo AB, Conde RA. Undifferentiated spondyloarthritis: a longterm followup. J Rheumatol 2010, 37(6):1195-1199. 10.3899/jrheum.090625, 20436080.
48. Collantes E, Veroz R, Escudero A. Can some cases of 'possible' spondyloarthropathy be classified as 'definite' or 'undifferentiated' spondyloarthropathy?Value of criteria for spondyloarthropathies. Spanish Spondyloarthropathy Study Group. Joint Bone Spine 2000, 67:516-520. 10.1016/S1297-319X(00)00201-3, 11195314.
49. Zeidler H, Mau W, Khan MA. Undifferentiated spondyloarthropathies. Rheum Dis Clin North Am 1992, 18:187-202.
50. Ansell BM, Bywaters EG. Diagnosis of " probable" Still's disease and its outcome. Ann Rheum Dis 1962, 21:253-262. 10.1136/ard.21.3.253, 1007284, 14013277.
51. Schaller JG, Ochs HD, Thomas ED. Histocompatibility antigens in childhood-onset arthritis. Pediatr 1976, 88:926-930.
52. Hussein A, Abdul-Khaliq H, von der Hardt H. A typical spondyloarthritis in children: proposed diagnostic criteria. Eur J Pediatr 1989, 148(6):513-517. Review, 10.1007/BF00441545, 2663507.
53. Jacobs JC, Johnston AD, Berdon WE. HLA-B27 associated spondyloarthritis and enthesopathy in childhood: clinical, pathologic and radiographic observations in 58 patients. J Pediatr 1982, 100:521-528. 10.1016/S0022-3476(82)80746-4, 6977633.
54. Rosenberg AM, Petty RE. A syndrome of seronegative enthesopathy and arthropathy in children. Arthritis Rheum 1982, 25:1041-1047. 10.1002/art.1780250902, 7126288.
55. Hall MA, Burgos-Vargas R, Ansell BM. Sacroiliitis in juvenile chronic arthritis: a 10 year follow-up. Clin Exp Rheumatol 1987, 5(Suppl):65-67.
56. Sheerin KA, Giannini EH, Brewer EJ. HLA-B27-associated arthropathy in childhood: long-term clinical and diagnostic outcome. Arthritis Rheum 1988, 31:1165-1170. 10.1002/art.1780310912, 3269216.
57. Burgos-Vargas R, Clark P. Axial involvement in the seronegative enthesopathy and arthropathy syndrome and its progression to ankylosing spondylitis. J Rheumatol 1989, 16:192-197.
58. Cabral DA, Oen KG, Petty RE. SEA syndrome revisited: a long term followup of children with a syndrome of seronegative enthesopathy and arthropathy. J Rheumatol 1992, 19:1282-1285.
59. Olivieri I, Foto M, Ruju GP. Low frequency of axial involvement in Caucasian pediatric patients with seronegative enthesopathy and arthropathy syndrome after 5 years of disease. J Rheumatol 1992, 19(3):469-475.
60. Burgos-Vargas R, Vázquez-Mellado J. The early clinical recognition of juvenile-onset ankylosing spondylitis and its differentiation from juvenile rheumatoid arthritis. Arthritis Rheum 1995, 38:835-844. 10.1002/art.1780380618, 7779128.
61. Flato B, Smerdel A, Johnston V. The influence of patient characteristics, disease variables, and HLA alleles on the development of radiographically evident sacroiliitis in juvenile idiopathic arthritis. Arthritis Rheum 2002, 46:986-994. 10.1002/art.10146, 11953976.
62. Poddubnyy D, Rudwaleit M, Haibel H, Listing J, Märker-Hermann E, Zeidler H, Braun J, Sieper J. Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann Rheum Dis 2011, 70:1369-1374. 10.1136/ard.2010.145995, 21622969.
63. Flatø B, Hoffmann-Vold AM. Long-term outcome and prognostic factors in enthesitis-related arthritis: a case-control study. Arthritis Rheum 2006, 54(11):3573-3582. 10.1002/art.22181, 17075863.
64. Burgos-Vargas R, Vázquez-Mellado J, Cassis N. Genuine ankylosing spondylitis in children: a case control study of patients with definite disease according to current adultonset criteria shortly after onset. J Rheumatol 1996, 23:2140-2147.
65. Rudwaleit M, Haibel H, Baraliakos X. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 2009, 60:717-727. 10.1002/art.24483, 19248087.
66. Heuft-Dorenbosch L, Landewé R, Weijers R. Performance of various criteria sets in patients with inflammatory back pain of short duration; the Maastricht early spondyloarthritis clinic. Ann Rheum Dis 2007, 66:92-98. 1798391, 16868021.
67. Bennett AN, McGonagle D, O'Connor P. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 2008, 58(11):3413-3418. 10.1002/art.24024, 18975311.
68. Chung HY, Machado P, van der Heijde D. HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis. Ann Rheum Dis 2011, 70(11):1930-1936. 10.1136/ard.2011.152975, 21803752.
69. Sieper J, Rudwaleit M. How early should ankylosing spondylitis be treated with tumour necrosis factor blockers?. Ann Rheum Dis 2005, 64(Suppl 4):iv: 61-iv: 64.
70. Brandt HC, Spiller I, Song IH. Performance of referral recommendations in patients with chronic back pain and suspected axial spondyloarthritis. Ann Rheum Dis 2007, 66:1479-1484. 10.1136/ard.2006.068734, 2111623, 17456526.
71. Pedersen SJ, Sørensen IJ, Hermann KG. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors. Ann Rheum Dis 2010, 69(6):1065-1071. 10.1136/ard.2009.111187, 19740906.
72. Song IH, Hermann K, Haibel H. Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial. Ann Rheum Dis 2011, 70(4):590-596. 10.1136/ard.2010.139667, 3211465, 21372193.
73. Song IH, Hermann KG, Haibel H. Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48. Ann Rheum Dis 2011, 70(7):1257-1263. 10.1136/ard.2010.147033, 3103667, 21551507.
74. Prieur AM, Listrat V, Dougados M. Criteres de classification des spondyloarthropathies chez les enfants. [Spondyloarthropathies classification criteria in children]. Arch Franc Ped 1993, 50:379-385. [in French].